Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

08.06.2021 | case report

Breast implant-associated anaplastic large-cell lymphoma: a European case report and literature review

verfasst von: M.D. Federico Ghidinelli, M.D. Luigi Filippini, M.D. Paola Porsio, M.D. Federico Canzi, M.D. Rino Balzano, M.D. Elisa Flocchini, M.D. Anna Bianchi

Erschienen in: memo - Magazine of European Medical Oncology

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCLC) is an infrequent T‑cell neoplasm that accounts for approximately 3% of non-Hodgkin lymphomas. After the first case of BIA-ALCL, an increasing number of scientific works concerning BIA-ALCL have been published. We report and discuss the case of BIA-ALCL in a 66-year-old Caucasian woman presented with swelling, pain, redness and a seroma that had developed around the breast implant. After establishing the diagnosis of BIA-ALCL (stage IC, T3N0M0 according to the BIA-ALCL staging system), she underwent several breast implant procedures and capsulectomies. We also provide the results of a literature review on the incidence, clinical management, diagnosis and therapy of this disease.
“Level of evidence: level IV case report with literature review”
Literatur
2.
Zurück zum Zitat Berry MG, Davies DM. Breast augmentation: part i—a review of the silicone prosthesis. J Plast Reconstr Aesthet Surg. 2010;63:1761–8. PubMedCrossRef Berry MG, Davies DM. Breast augmentation: part i—a review of the silicone prosthesis. J Plast Reconstr Aesthet Surg. 2010;63:1761–8. PubMedCrossRef
3.
Zurück zum Zitat Spear SL, Parikh PM, Goldstein JA. History of breast implants and the food and drug administration. Clin Plast Surg. 2009;36:15–21. PubMedCrossRef Spear SL, Parikh PM, Goldstein JA. History of breast implants and the food and drug administration. Clin Plast Surg. 2009;36:15–21. PubMedCrossRef
4.
Zurück zum Zitat Berry MG, Cucchiara V, Davies DM. Breast augmentation: part III-preoperative considerations and planning. J Plast Reconstr Aesthet Surg. 2011;64:1401–9. PubMedCrossRef Berry MG, Cucchiara V, Davies DM. Breast augmentation: part III-preoperative considerations and planning. J Plast Reconstr Aesthet Surg. 2011;64:1401–9. PubMedCrossRef
5.
Zurück zum Zitat Xu J, Wei S. Breast implant-associated anaplastic large cell lymphoma: review of a distinct clinicopathologic entity. Arch Pathol Lab Med. 2014;138:842–6. PubMedCrossRef Xu J, Wei S. Breast implant-associated anaplastic large cell lymphoma: review of a distinct clinicopathologic entity. Arch Pathol Lab Med. 2014;138:842–6. PubMedCrossRef
6.
Zurück zum Zitat Bizjak M, Selmi C, Praprotnik S, et al. Silicone implants and lymphoma: the role of inflammation. J Autoimmun. 2015;65:64–73. PubMedCrossRef Bizjak M, Selmi C, Praprotnik S, et al. Silicone implants and lymphoma: the role of inflammation. J Autoimmun. 2015;65:64–73. PubMedCrossRef
7.
Zurück zum Zitat Thompson PA, Lade S, Webster H, Ryan G, Prince HM. Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity. Haematologica. 2010;95:1977–9. PubMedPubMedCentralCrossRef Thompson PA, Lade S, Webster H, Ryan G, Prince HM. Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity. Haematologica. 2010;95:1977–9. PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90. PubMedPubMedCentralCrossRef Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90. PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat McCarthy CM, Loyo-Berríos N, Qureshi AA, et al. Patient registry and outcomes for breast implants and anaplastic large cell Lymphoma etiology and epidemiology (PROFILE): initial report of findings, 2012–2018. Plast Reconstr Surg. 2019;143:65S–73S. PubMedCrossRefPubMedCentral McCarthy CM, Loyo-Berríos N, Qureshi AA, et al. Patient registry and outcomes for breast implants and anaplastic large cell Lymphoma etiology and epidemiology (PROFILE): initial report of findings, 2012–2018. Plast Reconstr Surg. 2019;143:65S–73S. PubMedCrossRefPubMedCentral
10.
Zurück zum Zitat Groth K, Graf R. Breast implant-associated anaplastic large cell Lymphoma (BIA-ALCL) and the textured breast implant crisis. Aesthetic Plast Surg. 2020;44:1–12. CrossRef Groth K, Graf R. Breast implant-associated anaplastic large cell Lymphoma (BIA-ALCL) and the textured breast implant crisis. Aesthetic Plast Surg. 2020;44:1–12. CrossRef
11.
Zurück zum Zitat di Pompeo FS, Sorotos M, Clemens MW, Firmani G, European Association of Plastic Surgeons (EURAPS) Committee on device safety and development. Breast Implant–Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Review of epidemiology and prevalence assessment in Europe. Aesthet Surg J. 2020. https://​doi.​org/​10.​1093/​asj/​sjaa285. CrossRef di Pompeo FS, Sorotos M, Clemens MW, Firmani G, European Association of Plastic Surgeons (EURAPS) Committee on device safety and development. Breast Implant–Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Review of epidemiology and prevalence assessment in Europe. Aesthet Surg J. 2020. https://​doi.​org/​10.​1093/​asj/​sjaa285. CrossRef
12.
Zurück zum Zitat Quesada AE, Medeiros LJ, Clemens MW, Ferru MC, Miranda RN, Miranda RN. Breast implant-associated anaplastic large cell lymphoma: a review disorder. Modern Pathol. 2019;32:166–188. CrossRef Quesada AE, Medeiros LJ, Clemens MW, Ferru MC, Miranda RN, Miranda RN. Breast implant-associated anaplastic large cell lymphoma: a review disorder. Modern Pathol. 2019;32:166–188. CrossRef
13.
Zurück zum Zitat Case Report guidelines C. CARE Checklist of information to include when writing a case report. 2016; : 13. Case Report guidelines C. CARE Checklist of information to include when writing a case report. 2016; : 13.
14.
Zurück zum Zitat Grant Stevens W, Bradley Calobrace M, Alizadeh K, Zeidler KR, Harrington JL, d’Incelli RC. Ten-year core study data for sientra’s food and drug administration—approved round and shaped breast implants with cohesive silicone gel. Plast Reconstr Surg. 2018;141:7S–19S. PubMedCrossRef Grant Stevens W, Bradley Calobrace M, Alizadeh K, Zeidler KR, Harrington JL, d’Incelli RC. Ten-year core study data for sientra’s food and drug administration—approved round and shaped breast implants with cohesive silicone gel. Plast Reconstr Surg. 2018;141:7S–19S. PubMedCrossRef
15.
Zurück zum Zitat Kendall B, Sawyer RJ, Chang H, et al. No 主観的健康感を中心とした在宅高齢者における 健康関連指標に関する共分散構造分析 Title. Foresight. 2019;23:1–9. Kendall B, Sawyer RJ, Chang H, et al. No 主観的健康感を中心とした在宅高齢者における 健康関連指標に関する共分散構造分析 Title. Foresight. 2019;23:1–9.
16.
Zurück zum Zitat Gunawardana RT, Dessauvagie BF, Taylor DB. Breast implant-associated anaplastic large cell lymphoma, an under-recognised entity. J Med Imaging Radiat Oncol. 2019;63:630–8. PubMedCrossRef Gunawardana RT, Dessauvagie BF, Taylor DB. Breast implant-associated anaplastic large cell lymphoma, an under-recognised entity. J Med Imaging Radiat Oncol. 2019;63:630–8. PubMedCrossRef
17.
Zurück zum Zitat Gidengil CA, Predmore Z, Mattke S, Van Busum K, Kim B. Breast implant-associated anaplastic large cell lymphoma: a systematic review. Plast Reconstr Surg. 2015;135:713–20. PubMedCrossRef Gidengil CA, Predmore Z, Mattke S, Van Busum K, Kim B. Breast implant-associated anaplastic large cell lymphoma: a systematic review. Plast Reconstr Surg. 2015;135:713–20. PubMedCrossRef
18.
Zurück zum Zitat Yoshida SH, Swan S, Teuber SS, Gershwin ME. Silicone breast implants: immunotoxic and epidemiologic issues. Life Sci. 1995;56:1299–310. PubMedCrossRef Yoshida SH, Swan S, Teuber SS, Gershwin ME. Silicone breast implants: immunotoxic and epidemiologic issues. Life Sci. 1995;56:1299–310. PubMedCrossRef
19.
Zurück zum Zitat Kricheldorff J, Fallenberg EM, Solbach C, Gerber-Schäfer C, Rancsó C, Von Fritschen U. Brustimplantat-assoziiertes Lymphom. Dtsch Arztebl Int. 2018;115:625–35. übersichtsarbeit. Kricheldorff J, Fallenberg EM, Solbach C, Gerber-Schäfer C, Rancsó C, Von Fritschen U. Brustimplantat-assoziiertes Lymphom. Dtsch Arztebl Int. 2018;115:625–35. übersichtsarbeit.
20.
Zurück zum Zitat Lazzeri D, Agostini T, Bocci G, et al. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity. Clin Breast Cancer. 2011;11:283–96. PubMedCrossRef Lazzeri D, Agostini T, Bocci G, et al. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity. Clin Breast Cancer. 2011;11:283–96. PubMedCrossRef
21.
Zurück zum Zitat Zucca E, Bertoni F, Vannata B, Cavalli F. Emerging role of infectious etiologies in the pathogenesis of marginal zone B‑cell lymphomas. Clin Cancer Res. 2014;20:5207–16. PubMedCrossRef Zucca E, Bertoni F, Vannata B, Cavalli F. Emerging role of infectious etiologies in the pathogenesis of marginal zone B‑cell lymphomas. Clin Cancer Res. 2014;20:5207–16. PubMedCrossRef
22.
Zurück zum Zitat Hu H, Jacombs A, Vickery K, Merten SL, Pennington DG, Deva AK. Chronic biofilm infection in breast implants is associated with an increased t‑cell lymphocytic infiltrate: Implications for breast implant-associated lymphoma. Plast Reconstr Surg. 2015;135:319–29. PubMedCrossRef Hu H, Jacombs A, Vickery K, Merten SL, Pennington DG, Deva AK. Chronic biofilm infection in breast implants is associated with an increased t‑cell lymphocytic infiltrate: Implications for breast implant-associated lymphoma. Plast Reconstr Surg. 2015;135:319–29. PubMedCrossRef
23.
Zurück zum Zitat Hu H, Johani K, Almatroudi A, et al. Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma. Plast Reconstr Surg. 2016;137:1659–69. PubMedCrossRef Hu H, Johani K, Almatroudi A, et al. Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma. Plast Reconstr Surg. 2016;137:1659–69. PubMedCrossRef
24.
Zurück zum Zitat Laurent C, Nicolae A, Laurent C, et al. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL. Blood. 2020;135:360–70. PubMedPubMedCentral Laurent C, Nicolae A, Laurent C, et al. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL. Blood. 2020;135:360–70. PubMedPubMedCentral
25.
Zurück zum Zitat Technologies A, Diego S. Targeted next generation sequencing of breast implant—associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A. Br J Haematol. 2018;180:735–760. CrossRef Technologies A, Diego S. Targeted next generation sequencing of breast implant—associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A. Br J Haematol. 2018;180:735–760. CrossRef
27.
Zurück zum Zitat Tabanelli V, Corsini C, Fiori S, et al. Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant–associated anaplastic large cell lymphomas. Hum Pathol. 2019;90:60–9. PubMedCrossRef Tabanelli V, Corsini C, Fiori S, et al. Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant–associated anaplastic large cell lymphomas. Hum Pathol. 2019;90:60–9. PubMedCrossRef
29.
30.
Zurück zum Zitat Marra A, Viale G, Pileri SA, et al. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review. Cancer Treat Rev. 2020;84:101963. PubMedCrossRef Marra A, Viale G, Pileri SA, et al. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review. Cancer Treat Rev. 2020;84:101963. PubMedCrossRef
31.
Zurück zum Zitat Freeman. 乳鼠心肌提取 HHS public access. Physiol Behav. 2018;176:139–48. Freeman. 乳鼠心肌提取 HHS public access. Physiol Behav. 2018;176:139–48.
32.
Zurück zum Zitat Leberfinger AN, Behar BJ, Williams NC, et al. Breast implant-associated anaplastic large cell lymphoma: a systematic review. JAMA Surg. 2017;152:1161–8. PubMedCrossRef Leberfinger AN, Behar BJ, Williams NC, et al. Breast implant-associated anaplastic large cell lymphoma: a systematic review. JAMA Surg. 2017;152:1161–8. PubMedCrossRef
33.
Zurück zum Zitat Brody GS, Deapen D, Taylor CR, et al. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 casesa. Plast Reconstr Surg. 2015;135:695–705. PubMedCrossRef Brody GS, Deapen D, Taylor CR, et al. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 casesa. Plast Reconstr Surg. 2015;135:695–705. PubMedCrossRef
34.
Zurück zum Zitat Doren EL, Miranda RN, Selber JC, et al. U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2017;139:1042–50. PubMedCrossRef Doren EL, Miranda RN, Selber JC, et al. U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2017;139:1042–50. PubMedCrossRef
35.
Zurück zum Zitat Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J . 2019;39:S3–S13. PubMedCrossRef Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J . 2019;39:S3–S13. PubMedCrossRef
36.
37.
Zurück zum Zitat Chott A, Vonderheid EC, Olbricht S, Miao NN, Balk SP, Kadin ME. The same dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. J Invest Dermatol. 1996;106:696–700. PubMedCrossRef Chott A, Vonderheid EC, Olbricht S, Miao NN, Balk SP, Kadin ME. The same dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. J Invest Dermatol. 1996;106:696–700. PubMedCrossRef
38.
Zurück zum Zitat Laurent C, Delas A, Gaulard P, et al. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol. 2016;27:306–14. PubMedCrossRef Laurent C, Delas A, Gaulard P, et al. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol. 2016;27:306–14. PubMedCrossRef
39.
Zurück zum Zitat Ten Berge RL, Oudejans JJ, Ossenkoppele GJ, et al. ALK expression in extranodal anaplastic large cell lymphoma layouts systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination. J Clin Pathol. 2000;53:445–50. PubMedCrossRef Ten Berge RL, Oudejans JJ, Ossenkoppele GJ, et al. ALK expression in extranodal anaplastic large cell lymphoma layouts systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination. J Clin Pathol. 2000;53:445–50. PubMedCrossRef
40.
Zurück zum Zitat Gascoyne RD, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood. 1999;93:3913–21. PubMedCrossRef Gascoyne RD, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood. 1999;93:3913–21. PubMedCrossRef
41.
Zurück zum Zitat Munakata W, Terauchi T, Maruyama D, Nagai H. Revised staging system for malignant lymphoma based on the Lugano classification. Jpn J Clin Oncol. 2019;49:895–900. PubMedCrossRef Munakata W, Terauchi T, Maruyama D, Nagai H. Revised staging system for malignant lymphoma based on the Lugano classification. Jpn J Clin Oncol. 2019;49:895–900. PubMedCrossRef
42.
Zurück zum Zitat Clemens MW, Medeiros LJ, Butler CE, et al. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol. 2016;34:160–8. PubMedCrossRef Clemens MW, Medeiros LJ, Butler CE, et al. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol. 2016;34:160–8. PubMedCrossRef
43.
Zurück zum Zitat Younes A, Bartlett NL, Leonard JP, et al. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med. 2010;363:1812–21. PubMedCrossRef Younes A, Bartlett NL, Leonard JP, et al. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med. 2010;363:1812–21. PubMedCrossRef
44.
Zurück zum Zitat Prince HM, Kim YH, Horwitz S, et al. Brentuximab vedotin or physician’s choice in CD30-positive cutaneous T‑cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Lancet. 2017;390:555–66. PubMedCrossRef Prince HM, Kim YH, Horwitz S, et al. Brentuximab vedotin or physician’s choice in CD30-positive cutaneous T‑cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Lancet. 2017;390:555–66. PubMedCrossRef
45.
Zurück zum Zitat Johnson L, O’Donoghue JM, McLean N, et al. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent. Eur J Surg Oncol. 2017;43:1393–401. PubMedCrossRef Johnson L, O’Donoghue JM, McLean N, et al. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent. Eur J Surg Oncol. 2017;43:1393–401. PubMedCrossRef
46.
Zurück zum Zitat Zimmerman A, Locke FL, Emole J, et al. Recurrent systemic anaplastic lymphoma kinase–negative anaplastic large cell lymphoma presenting as a breast implant–associated lesion. Cancer Control. 2015;22:369–72. PubMedCrossRef Zimmerman A, Locke FL, Emole J, et al. Recurrent systemic anaplastic lymphoma kinase–negative anaplastic large cell lymphoma presenting as a breast implant–associated lesion. Cancer Control. 2015;22:369–72. PubMedCrossRef
47.
Zurück zum Zitat Hwang MJ, Brown H, Murrin R, Momtahan N, Sterne GD. Breast implant-associated anaplastic large cell Lymphoma: a case report and literature review. Aesthetic Plast Surg. 2015;39:391–5. PubMedCrossRef Hwang MJ, Brown H, Murrin R, Momtahan N, Sterne GD. Breast implant-associated anaplastic large cell Lymphoma: a case report and literature review. Aesthetic Plast Surg. 2015;39:391–5. PubMedCrossRef
48.
Zurück zum Zitat Tardío JC, Granados R. Axillary lymphadenopathy: an outstanding presentation for breast implant-associated ALK-negative anaplastic large cell lymphoma. Int J Surg Pathol. 2015;23:424–8. PubMedCrossRef Tardío JC, Granados R. Axillary lymphadenopathy: an outstanding presentation for breast implant-associated ALK-negative anaplastic large cell lymphoma. Int J Surg Pathol. 2015;23:424–8. PubMedCrossRef
50.
Zurück zum Zitat Clemens MW, Miranda RN, Butler CE. Breast implant informed consent should include the risk of anaplastic large cell lymphoma. Plast Reconstr Surg. 2016;137:1117–22. PubMedCrossRef Clemens MW, Miranda RN, Butler CE. Breast implant informed consent should include the risk of anaplastic large cell lymphoma. Plast Reconstr Surg. 2016;137:1117–22. PubMedCrossRef
52.
Zurück zum Zitat Somogyi RB, Ziolkowski N, Osman F, Ginty A, Brown M. Breast reconstruction: updated overview for primary care physicians. Can Fam Physician. 2018;64:424–32. PubMedPubMedCentral Somogyi RB, Ziolkowski N, Osman F, Ginty A, Brown M. Breast reconstruction: updated overview for primary care physicians. Can Fam Physician. 2018;64:424–32. PubMedPubMedCentral
Metadaten
Titel
Breast implant-associated anaplastic large-cell lymphoma: a European case report and literature review
verfasst von
M.D. Federico Ghidinelli
M.D. Luigi Filippini
M.D. Paola Porsio
M.D. Federico Canzi
M.D. Rino Balzano
M.D. Elisa Flocchini
M.D. Anna Bianchi
Publikationsdatum
08.06.2021
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-021-00714-4